Locations:
Search IconSearch
February 8, 2021/Cancer/Patient Support

New NCCN Guidelines Focus on Key Aspects of Survivorship

Patient resources promote healthy living, management of late and long-term side effects

Cancer survivor

Two new guidelines from the National Comprehensive Cancer Network (NCCN) offer jargon-free information that clinicians can use to help counsel and educate patients about what comes after an initial cancer diagnosis and therapy for the disease.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Part of NCCN’s “Survivorship” series, the publications address late and long-term effects of cancer and cancer treatment, and factors that are key to healthy living. Designed for patients with adult-onset cancer, they are applicable whether an individual’s cancer treatment is ongoing or has been paused, stopped, or completed. 

“Primary care physicians can’t be experts in all of the areas covered in the NCCN physician guidelines, and these guidelines can help them understand what sort of issues survivors they see may be facing and provide appropriate resources or referrals,” says Halle C.F. Moore, MD, Director of the Breast Cancer Program at Cleveland Clinic Cancer Center. “The patient guidelines are ideal for use at the time of a comprehensive survivorship assessment, during which treatment, symptoms or delayed effects may be discussed.”

Broad and multidisciplinary consensus

Endorsed by Good Days, the American Lung Association, Be the Match, the Cancer Hope Network, the Save Your Skin Foundation, and The Leukemia & Lymphoma Society, the guidelines were developed by a panel of experts. Among them are oncologists and specialists in bone marrow transplantation, urology, cardiology and psychology, as well as a primary care physician, nutrition scientist, nurse, epidemiologist and a sociologist.

“The group is a pretty broad and multidisciplinary group, and it includes at least one cancer survivor,” says Dr. Moore, who represents the Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center and Cleveland Clinic on the panel. “We come together to update the guidelines every year, based on a thorough review of the current literature and expert opinion. That process informs development of recommendations based on consensus grading.”

Advertisement

Screening and cardiovascular risk updates

The new publication on cancer-related late and long-term effects covers topics such as lymphedema, cognitive dysfunction, sexual dysfunction, fatigue, sleep, pain and distress and mental health. The two most noteworthy additions to it in 2020, according to Dr. Moore, are an expanded section on cardiovascular disease risk and a significant update related to screening for subsequent primary malignancies.

“We know that cancer survivors are at higher risk for cardiovascular disease for a variety of reasons, which may be related to their treatment or to shared risk factors for cancer and cardiovascular disease — smoking, age and obesity, among others,” she says. “The guidelines provide tools that clinicians can use to assess traditional and cancer treatment-related risk factors when guiding patients and recommendations for counseling to help mitigate those risks.”

The healthy living guideline reviews physical activity, food and supplements, weight and metabolism, and prevention of infections. Both publications include an appendix with resources and a glossary of key terms, as well as listings of NCCN cancer centers. “Survivorship Care for Healthy Living” and “Survivorship Care for Cancer-Related Late and Long-Term Effects” are available for free to view and print at NNCN.org/patients or via the NCCN Patient Guides for Cancer App.

“Good care for cancer survivors begins at diagnosis and can improve a patient’s health, wellness and quality of life,” says Dr. Moore. “These NCCN publications can further that goal by facilitating coordination of care between primary care physicians, oncologists and other clinicians, and providing evidence-based guidance on health maintenance, screening for and evaluation of consequences of cancer and cancer treatment.”

Advertisement

Related Articles

Hospice nurse with patient
March 10, 2026/Cancer/News & Insight

Centering End-of-Life Care Around What Matters Most

Goal-of-care discussions drive earlier hospice access

Dr. Lauren Kopicky headshot
March 4, 2026/Cancer/Podcast

Rethinking Axillary Management in Breast Cancer (Podcast)

Clinical trials and de-escalation strategies

Lobular breast cancer cells
February 26, 2026/Cancer/News & Insight

Standard of Care for Hormone-Sensitive Advanced Breast Cancer Also Effective for Lobular Subgroup

Combination therapy improves outcomes, but lobular patients still do worse overall than ductal counterparts

Person hugging in support group
February 25, 2026/Cancer/Patient Support

Treating Substance Use Disorder in Patients with Cancer

Bringing empathy and evidence-based practice to addiction medicine

Drs. Turk and Khatri headshots
February 23, 2026/Cancer/Podcast

Beyond Mammography (Podcast)

Supplemental screening for dense breasts

Dr. Elvin Zan headshot
February 17, 2026/Cancer/Podcast

Expanding Cancer Treatment with Theranostics (Podcast)

Combining advanced imaging with targeted therapy in prostate cancer and neuroendocrine tumors

Man touching lymph nodes
February 12, 2026/Cancer/News & Insight

EGFR-MET Bispecific Antibody Shows Promise for Metastatic Head & Neck Cancer

Early results show strong clinical benefit rates

Bispecific antibodies
February 10, 2026/Cancer/Blood Cancers

MajesTEC-3 Trial Outcomes May Change Course of Myeloma Treatment

The shifting role of cell therapy and steroids in the relapsed/refractory setting

Ad